Journal article
Activation of the alternate renin-angiotensin system correlates with the clinical status in human cirrhosis and corrects post liver transplantation
S Casey, R Schierwagen, KY Mak, S Klein, F Uschner, C Jansen, M Praktiknjo, C Meyer, D Thomas, C Herath, R Jones, J Trebicka, P Angus
Journal of Clinical Medicine | Published : 2019
DOI: 10.3390/jcm8040419
Abstract
Introduction: Recent animal studies have shown that the alternate renin-angiotensin system (RAS) consisting of angiotensin-converting enzyme 2 (ACE2), angiotensin-(1–7) (Ang-(1–7)) and the Mas receptor is upregulated in cirrhosis and contributes to splanchnic vasodilatation and portal hypertension. To determine the potential relevance of these findings to human liver disease, we evaluated its expression and relationship to the patients’ clinical status in subjects with cirrhosis. Methods: Blood sampling from peripheral and central vascular beds was performed intra-operatively for cirrhotic patients at the time of liver transplantation (LT) or trans-jugular intra-hepatic portosystemic shunt (..
View full abstractRelated Projects (1)
Grants
Awarded by Horizon 2020 Framework Programme
Funding Acknowledgements
This work was funded in part by a National Health and Medical Research Council (NHMRC) of Australia Project Grant and Deutsche Forschungsgemeinschaft (SFB TRR57 P18). JT received funding by the European Union's Horizon 2020 research and innovation program's GALAXY study (No. 668031), LIVERHOPE (No. 731875) and MICROB-PREDICT (No. 825694) and the Cellex Foundation.